These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3019373)
21. Relative value of various etiological factors in short lasting, adverse psychological reactions to cannabis smoking. Negrete JC Br J Addict Alcohol Other Drugs; 1973 Oct; 68(3):221-9. PubMed ID: 4150632 [No Abstract] [Full Text] [Related]
22. Cannabis psychosis: examining the evidence for a distinctive psychopathology in a systematic and narrative review. Baldacchino A; Hughes Z; Kehoe M; Blair H; Teh Y; Windeatt S; Crome IB Am J Addict; 2012 Nov; 21 Suppl 1():S88-98. PubMed ID: 23786516 [TBL] [Abstract][Full Text] [Related]
24. Analgesics-antipyretics and etiology and pathogenesis of psychosis. Drtil J Act Nerv Super (Praha); 1971; 13(3):237-8. PubMed ID: 5113851 [No Abstract] [Full Text] [Related]
25. Psychosis secondary to long-term levamisole therapy. Jeffries JJ; Cammisuli S Ann Pharmacother; 1998 Jan; 32(1):134-5. PubMed ID: 9475841 [No Abstract] [Full Text] [Related]
26. Psychological adverse effects of cannabis smoking: a tentative classification. Nigrete JC Can Med Assoc J; 1973 Jan; 108(2):195-6 passim. PubMed ID: 4569453 [TBL] [Abstract][Full Text] [Related]
27. Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic. Dhir S; Khalid Z; Salcedo J; Shanbour A Prim Care Companion CNS Disord; 2020 Dec; 22(6):. PubMed ID: 33271642 [No Abstract] [Full Text] [Related]
28. First-Episode Psychosis Possibly due to Roxithromycin-Related Inhibition of Metabolization of Tetrahydrocannabinol. Gahr M; Hiemke C; Connemann BJ; Schönfeldt-Lecuona C J Clin Psychopharmacol; 2017 Jun; 37(3):369-370. PubMed ID: 28328793 [No Abstract] [Full Text] [Related]
29. [Pharmacopsychoses during drug addiction]. Cottereau MJ; Lôo H; Poirier MF; Deniker P Encephale; 1975; 1(1):43-8. PubMed ID: 1132368 [TBL] [Abstract][Full Text] [Related]
31. Exacerbation of psychosis by phenylpropanolamine. Goodhue A; Bartel RL; Smith NB Am J Psychiatry; 2000 Jun; 157(6):1021-2. PubMed ID: 10831490 [No Abstract] [Full Text] [Related]
32. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. van Amsterdam J; Brunt T; van den Brink W J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398 [TBL] [Abstract][Full Text] [Related]
33. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Koethe D; Gerth CW; Neatby MA; Haensel A; Thies M; Schneider U; Emrich HM; Klosterkötter J; Schultze-Lutter F; Leweke FM Schizophr Res; 2006 Dec; 88(1-3):142-50. PubMed ID: 17005373 [TBL] [Abstract][Full Text] [Related]
34. Psychotic episode induced by ovulation-initiating treatment. Altmark D; Tomer R; Sigal M Isr J Med Sci; 1987 Nov; 23(11):1156-7. PubMed ID: 3436800 [No Abstract] [Full Text] [Related]
35. Case of psychosis due to prednisone-clarithromycin interaction. Finkenbine RD; Frye MD Gen Hosp Psychiatry; 1998 Sep; 20(5):325-6. PubMed ID: 9788033 [No Abstract] [Full Text] [Related]
37. Severe psychological disturbance resulting from abuse of nasal decongestants. Blackwood GW Scott Med J; 1982 Apr; 27(2):175-6. PubMed ID: 6178154 [TBL] [Abstract][Full Text] [Related]
38. Psychoses associated with propranolol withdrawal. Golden RN; Hoffman J; Falk D; Provenzale D; Curtis TE Biol Psychiatry; 1989 Feb; 25(3):351-4. PubMed ID: 2914157 [No Abstract] [Full Text] [Related]